| |
property for sale in fethiye didim turkey
News and Information Article
CAMBRIDGE, Mass. and SAN FRANCISCO, Feb. 9 // -- Clarus
Ventures, LLC, a global lifesciences venture capital firm, today announced the
addition of three Principals and a Controller to its investment team.
Emmett Cunningham, MD, Ph.D., M.P.H., Michele Park, Ph.D., and Scott
Requadt, JD, MBA, have joined the firm as Principals. Danielle Bechard has
joined the firm as Controller.
"We are fortunate to have attracted such high caliber individuals to help
evaluate, grow and nurture our investments. Members of our team had previous
relationships with both Emmett Cunningham and Scott Requadt, when they were at
Eyetech and TransForm, respectively. It is a pleasure to be working with them
again," said Dr. Dennis Henner, Managing Director of Clarus Ventures.
Bios
Prior to joining the San Francisco office of Clarus Ventures, Dr. Emmett
Cunningham was Senior Vice President, Medical Strategy at Eyetech
Pharmaceuticals, Inc. At Eyetech, Dr. Cunningham played a leadership role in
the development and approval of Macugen for age-related macular degeneration.
Before that, Dr. Cunningham conducted clinical research at Pfizer, Inc. As an
ophthalmologist specializing in infectious and inflammatory eye disease, Dr.
Cunningham most recently served as Clinical Professor of Ophthalmology at New
York University School of Medicine, having also held a tenured position at the
University of California-San Francisco. Dr. Cunningham received his M.D. from
Johns Hopkins University, his Ph.D. in neuroscience from the University of
California-San Diego, and his M.P.H. in epidemiology and statistics from Johns
Hopkins University.
Dr. Michele Park joins the San Francisco office of Clarus Ventures from
Credit Suisse First Boston where she was an analyst covering large, medium and
small capitalization biotechnology companies with a focus on companies with
oncologic and anti-infective products. Dr. Park began her career as a
biotechnology analyst at Piper Jaffrey covering small and mid capitalization
companies. Dr. Park received her Ph.D. in molecular biology from Memorial
Sloan Kettering Institute.
Mr. Scott Requadt joins the Cambridge office of Clarus Ventures from
TransForm Pharmaceuticals, Inc. where he was Director of Business Development,
negotiating over ten corporate partnerships, overseeing a portfolio of over
200 patents and applications, and playing a critical role in the acquisition
of TransForm by Johnson & Johnson. Prior to TransForm, Mr. Requadt was a
Mergers & Acquisitions attorney at Davis Polk & Wardwell in New York. Mr.
Requadt received his JD degree from the University of Toronto and his MBA
degree from Harvard Business School.
Danielle Bechard also joins the Cambridge office of Clarus Ventures as
Controller. Ms. Bechard joins Clarus from the McDonalds Corporation where she
was responsible for franchisee analysis. Before that, Ms. Bechard was senior
auditor in the venture capital group of Price Waterhouse Coopers.
About Clarus Ventures:
Founded by a group of accomplished investment professionals with extensive
and complementary industry backgrounds, Clarus Ventures is a life sciences
venture capital firm with a team that has a long history of success in
creating value. Deep relationships with industry thought leaders and decision
makers allow this team to identify unique investment opportunities and
shepherd them to maturity. Clarus augments its core expertise of investing in
biopharmaceuticals and medical technology with deep and diverse expertise in
research and development, commercialization, business development and
operations management at the global level. The Firm manages $500 million
through its inaugural fund, Clarus Lifesciences I, L.P. and has offices in
Cambridge, MA and San Francisco, CA.
For additional information on Clarus Ventures please visit
http://www.clarusventures.com.
CONTACTS:
Nicholas Galakatos, Ph.D., Clarus Ventures, Tel.: 617-949-2223
Robert Liptak, Clarus Ventures, Tel.: 617-694-2222
Benjamin Carmichael, Noonan Russo, Tel.: 212-845-4242
| |
|
|
 |
property for sale in fethiye didim turkey |
|
|
|
|
|
|
|
|
|
Locations
